ALKS - Alkermes plc.
29.28
0.080 0.273%
Share volume: 1,753,106
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$29.20
0.08
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-01-2024 | 07-24-2024 | 10-24-2024 | 02-12-2025 | 05-01-2025 | 07-29-2025 | 10-28-2025 | 02-25-2026 | |
| Assets | |||||||||
| Total Assets | 2.124 B | 2.207 B | 2.155 B | 2.056 B | 2.082 B | 2.253 B | 2.330 B | 2.487 B | |
| Current Assets | 1.469 B | 1.542 B | 1.564 B | 1.415 B | 1.479 B | 1.635 B | 1.742 B | 1.929 B | |
| Inventories | 198.369 M | 194.731 M | 191.087 M | 182.887 M | 183.438 M | 191.924 M | 190.997 M | 196.625 M | |
| Other Current Assets | 98.021 M | 3.492 M | 2.969 M | 4.990 M | 3.049 M | 1.424 M | 717.000 K | 0.000 | |
| Short Term Investments | 324.295 M | 340.967 M | 512.571 M | 460.522 M | 484.211 M | 494.540 M | 494.665 M | 199.645 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 420.753 M | 535.150 M | 396.293 M | 291.146 M | 399.806 M | 521.199 M | 616.449 M | 388.570 M | |
| Total Non-current Assets | 62.782 M | 86.402 M | 18.920 M | 73.148 M | 32.189 M | 38.269 M | 27.869 M | 145.000 K | |
| Property Plant Equipment | 224.590 M | 222.738 M | 225.422 M | 227.564 M | 233.920 M | 239.399 M | 246.982 M | 221.722 M | |
| Other Assets | 430.481 M | 441.914 M | 365.691 M | 412.648 M | 369.007 M | 378.122 M | 340.866 M | 336.110 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 2.124 B | 2.207 B | 2.155 B | 2.056 B | 2.082 B | 2.253 B | 2.330 B | 2.487 B | |
| Total liabilities | 869.133 M | 922.837 M | 863.185 M | 590.590 M | 570.394 M | 628.225 M | 596.080 M | 667.698 M | |
| Total current liabilities | 458.977 M | 515.549 M | 453.705 M | 465.199 M | 443.730 M | 505.962 M | 474.360 M | 543.437 M | |
| Accounts Payable | 205.854 M | 239.774 M | 160.198 M | 185.332 M | 186.035 M | 245.749 M | 214.985 M | 289.565 M | |
| Other liabilities | 123.061 M | 120.829 M | 123.657 M | 125.391 M | 126.664 M | 122.263 M | 121.720 M | 124.261 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 287.095 M | 286.459 M | 285.823 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 123.061 M | 120.829 M | 123.657 M | 125.391 M | 126.664 M | 122.263 M | 121.720 M | 124.261 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.255 B | 1.284 B | 1.292 B | 1.465 B | 1.512 B | 1.625 B | 1.733 B | 1.819 B | |
| Common stock | 2.783 B | 2.806 B | 2.834 B | 2.863 B | 2.915 B | 2.943 B | 2.969 B | 3.006 B | |
| Retained earnings | -1.307 B | -1.215 B | -1.123 B | -976.458 M | -953.994 M | -866.896 M | -784.135 M | -734.794 M |